MicroVention Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • MicroVention's estimated annual revenue is currently $741M per year.(i)
  • MicroVention's estimated revenue per employee is $251,000

Employee Data

  • MicroVention has 2952 Employees.(i)
  • MicroVention grew their employee count by 7% last year.

MicroVention's People

NameTitleEmail/Phone
1
Sr. Executive Assistant To CEOReveal Email/Phone
2
Executive Assistant to CEOReveal Email/Phone
3
Sr. VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
4
Chief Commercial Officer (CCO)Reveal Email/Phone
5
Chief People OfficerReveal Email/Phone
6
SVP Regulatory Affairs, Clinical Research and Quality Reveal Email/Phone
7
VP, Global QualityReveal Email/Phone
8
VP, Business Operations & Finance EMEAReveal Email/Phone
9
VP, Global Clinical ResearchReveal Email/Phone
10
Head Regulatory Affairs for Aneurysm and Peripheral DevicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is MicroVention?

MicroVention, a privately-held company, was founded in 1997 with the strategic objective of developing and marketing medical devices to enable or significantly improve the treatment of vascular diseases in small vessels. The current focus is on catheter-based products for endovascular treatment of neurovascular diseases, serving the specialty of interventional neuroradiology. The Company’s lead product, the MicroPlex Coil System, is a uniquely designed embolization device for the treatment of cerebral aneurysms. In development is a revolutionary, next-generation device called the HydroCoil Embolization System.

keywords:N/A

N/A

Total Funding

2952

Number of Employees

$741M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MicroVention News

2022-04-17 - Microvention announces enrolment of first patient in STRAIT ...

Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the successful completion of its first patient enrolment in a...

2022-04-17 - MicroVention begins subject enrolment in balloon guide ...

MicroVention president and CEO Carsten Schroeder said: “The STRAIT trial is intended to provide clinical evidence that MicroVention's new...

2022-04-17 - MicroVention Announces First Patient Enrolled in the STRAIT ...

noted that, "The STRAIT trial is intended to provide clinical evidence that MicroVention's new balloon guide catheter can effectively contribute...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$782M3852-2%N/A
#2
$903.8M4452N/AN/A